Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection

Journal of Physiology and Pharmacology

Volumn 47, Issue 1, 1996, Pages 5-19

  Konturek, P Ch ^b   Konturek, J W ^b   Konturek, S J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER PYLORI; HISTORY OF MEDICINE; HUMAN; POLAND; REVIEW; STOMACH ULCER;

ANIMALS; DUODENAL ULCER; GASTRIC ACID; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; POLAND; STOMACH DISEASES; TIME FACTORS;

EID: 0029935263     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Bottcher G. Dorpater Med Z 1874; 5: 148,
2. Bizzozero G. Sulle ghiandale tubulari del tube gastroenterico e sui rapporti dellero coll epithelio de rivestimento della mucosa Atti d R Accad delle Sci di Torino 1892; 28: 233-251.
3. Jaworski W. Podrȩcznik Chorób żola̧dka (Handbook of Gastric Diseases). Wydawniciwa Dziel Lekarskich Polskich 1899; p. 32.
4. Salomon H. Ueber das Spirillum des Saugtiermagens und sein Verhalten zu den Belegzellen. Zentralbl Bakteriol 1896; 19: 433-442.
5. Krienitz W. Ueber das Auftreten von Spirochaetne vershiegener Form im Magen-inhalt bei Carcinoma ventriculi. Dtsch Med Wochenschr 1906; 32: 872.
6. Doenges JL. Spirochaetes in gastric glands of macacus rhesus and humans without definite history of related disease. Proc Soc Exp Biol Med 1938; 38: 536-538.
7. Freedberg AS, Barron LE. The presence of spirochaetes in human gastric mucosa. Am J Dig Dis 1940; 38: 443-445.
8. Palmer ED. Investigation of the gastric mucosa spirochaetes of the humans. Gastroenterology 1954; 27: 218-220.
9. Schwarz K. Ueber penetriende Magen- und Jejunalgeschwüre. Beitrage Klin Chir 1910; 68: 96-111.
10. Luck JM, Seth TN. Gastric urease. Biochem J 1924; 18: 1227-1231.
11. Langenberg M, Tytgat GN, Schipper MES. Campylobacter-like organism in the stomach of patients and healthy individuals (letter). Lancet 1984; 1: 1348-1349.
12. Steer HW. Ultrastucture of cell migration through the gastric epithelium and its relation to bacteria. J Clin Pathol 1975, 28: 639-646.
13. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273.
14. Marshall BJ. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275.
15. Marshall BJ, Royce H, Annear DL Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbiol Lett 1984; 25: 83-88.
16. Marshall BJ, Armstrong JA, McGenchie DB, Glamcy RJ. Altempt to fullfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-439.
17. Rollason TP, Stone J, Rhodes JM. Spiral organisms in endoscopic biopsies of the human stomach. J Clin Pathol 1984; 37: 23-26.
18. Steer HW. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 1984; 25: 1203-1210.
19. Hu LT, Mobley HL. Expression of catalytically active recombinant Helicobacter pylori urease at wild-type levels in Escherichia coli. Infect Immun 1993; 61: 2563-2569.
20. Marshall BJ, Barrett LJ, Prakash C et al. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990; 99: 697-702.
21. Eaton KA, Brooks CL, Morgan DR, Krakowska S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470-2475.
22. Mauch F, Bode G, Malfertheiner P. Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors (letter). Am J Gastroenterol 1993; 88: 1801-1802.
23. Calam J. Climan's Guide to Helicobacter pylori. Chapman and Hall Med 1996: p. 3-92
24. Logan RPH, Walker MM, Misiewicz JJ et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-16.
25. Narikawa S, Imai N, Sakama S et al. Evaluation of agar media of growth of Campylobacter pylori. Rinsho Byori 1990; 38: 104-106.
26. Lingwood CA, Wasfy G, Han H, Huesca M. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect Immun 1993; 61: 2474-2478.
27. Wyatt JI, Rathbone BJ, Sobala GM et al. Gastric epitheliun in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981-986.
28. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992; 87: 1598-1600.
29. Atherton JC, Cover TL, Peek RM, Blaser MJ. Subtyping of Helicobacter pylori strains into two groups by polymerase chain reaction amplification of the vacA gene and correlation of these groups with CagA status. Am J Gastroenterol 1994; 89: 1291.
30. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799-1806.
31. Hessey SJ, Spencer J, Wyatt JI et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134-138.
32. 2 activity: a factor in peptic ulcer production? J Clin Pathol 1992; 45: 221-224.
33. Mooney C, Keenan J, Munster D et al. Neutrophil activation by Helicobacter pylori. Gut 1991; 32: 853-857.
34. Kozol R, McCurdy B, Czanko R. A neutrophil chemotactic factor present in H.pylori but absent in H mustelae.Dig Dis Sci 1993; 38: 137-141.
35. Rautelin H, Blomberg B, Fredlund H et al. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599-603.
36. Stachura J, Konturek JW, Karczewska E, Konturek SJ, Domschke W. Helicobacter pylori expresses inducible nitric oxide synthase. J Physiol Pharmacol 1996; 47: 1, 131-135.
37. Sobhani I, Bado A, Yacine C et al. Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. J Physiol Pharmacol 1966; 47: 1, 177-185.
38. Mégraud F, Neman Simha V, Brugmann D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect Immun 1992; 60: 1858-1863.
39. Suzuki M, Muira S, Suematsu M, Fukumura D, Kurose I, Suzuki H. Helicobacter pylori associated ammonia production enhances neutrophil- dependent gastric mucosal cell damage. Am J Physiol 1992; 263: G718-725.
40. Tsuji M, Kawano S, Tsuji S, Fsamoto H, Kamada T, Sato N. Mechanism of gastric mucosal damage by ammonia. Gastroenterology 1992; 102: 1881-1888.
41. Tsujii M, Kawano S, Tsuji S et al. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterology 1993; 104: 796-801.
42. Takeuchi K, Ohuchi T, Harada H, Okabe S. Irritant and protective action of urea-urease ammonia in rat gastric mucosa. Dig Dis Sci 1955; 40: 274-281.
43. Brzozowski T, Konturek P, Sliwowski Z, Szlachcic A, Hahn EG, Konturek SJ. Adaptive cytoprotection by ammonia and urea-urease system in the rat gastric mucosa. J Physiol Pharmacol 1995; 46: 471-488.
44. El Nujumi AM, Rowe PA, Dahill S et al. Role of ammonia in the pathogenesis of the gastritis, hypergastinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut 1992; 33: 1612-1616.
45. Graham DY, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974-980.
46. Ramsey EJ, Carey KV, Peterson WL. Epidemic gastritis with hypochlorhydria. Gastroenterology 1979; 76: 1449-1457.
47. Cave DR, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187-189.
48. Tache Y, Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1. Ann NY Acad Sci 1992; 664: 353-368.
49. Nielsen H, Birkholz S, Andersen LP, Moran AP. Neutrophil activation by Helicobacter pylori lipopoiysaccharides. J Infect Dis 1994; 170: 135-139.
50. Noach LA, Bosma NB et al. Mucosal tumor necrosis factor-alpha, interieukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-429.
51. Dunn BE, Roop RM, Sung CC et al. Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori. Infect Immun 1992; 60: 1946-1951.
52. Davies GR, Simmonds NJ, Stevens TR et al. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467-1472.
53. Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244-251.
54. Sipponen P. Natural history of gastritis and its relationship to peptic ulcer disease. Digestion 1992; 51 (suppl 1): 70-75.
55. Fong TL, Dooley CP, Dehesa M. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 1991; 100: 328-332.
56. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in duodenal ulcer patients: effect of eradication of H.pylori. Gut 1993; 34: 888-892.
57. Tarnasky PR, Kovacs TO, Sytnik B, Walsh JH. Asymptomatic H.pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993; 38: 1681-1687.
58. Beardshall K, Moss S, Gill J et al. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut 1992; 33: 601-603.
59. Graham DY, Opekun A, Lew GM, Klein PD, Walsh JH. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gasstroenterology 1991; 100: 1571-1575.
60. El-Omar E, Penman I, Dorrian CA et al. Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two-thirds in duodenal ulcer patients. Gut 1993; 34: 1060-1065.
61. McHenry L, Jr, Vuyyuru L, Schubert ML. Helicobacter pylori and duodenal ulcer disease: the somatostatin link? Gastroenterology 1993; 104: 1573-1575.
62. Levi S, Beardshall K, Haddad G et al. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167-1168.
63. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.
64. Kaneko H, Nakada K. Mitsuma T et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992; 37: 409-416.
65. El-Nujumi AM, Rowe PA, Dahill S, Dorrian CA, Neithercut WD, McColl KE. Role of ammonia in the pathogenesis of the gastritis, hypergastrinemia and hyperpepsinemia I caused by Helicobacter pylori infection. Gut 1992; 33: 1612-1616.
66. Konturek JW, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroent 1995; 30: 738-744.
67. Konturek JW, Stoll R, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion in man. Gut 1990; 34: 321-328.
68. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibition effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-487.
69. Konturek PCh, Konturek SJ. Helicobacter pylori infection in gastroduodenal secretion and pathogenesis of peptic ulcer and gastric. J Physiol Pharmacol 1994; 45: 333-350.
70. Konturek JW, Bielanski W, Konturek SJ, Domschke W. Eradication of Helicobacter pylori and gastrn-somatostatn lnk in duodenal ulcer patients. J Physiol Pharmacol 1996, 47: 161-175.
71. Saita H, Murakami M, Dekigai H, Kita T. Effects of ammonia and monochloramine in gastrin release and acid secretion. Gastroenterology 1993; 104: A183.
72. Golonder EH, Territo MC, Walsh JH, Soll AH. Stimulation of gastrin release from cultured canine G cells by Helicobacter pylori and mononuclear cells. Gastroenterology 1992; 102: A630.
73. Golodner EH, Soll AH, Walsh JH, Calam J. Release of gastrin from cultured canine G-cells by interferon-gamma and tumour necrosis factor-alpha. Gastroenterology 1993; 104: A89.
74. Beales I, Srinivasal S, Blaser M et al. Effect of Helicobacter pylori constituents and inflammatory cytokines on gastrin release from isolated canine G cells. Gastroenterology 1995; 108: A779.
75. Karnes WE. Epidermal growth factor and transforming growth factor-alfa. In: Gut Peptides: Biochemistry and Physiology, JW Walsk, GJ Dockray (eds). Raven Press, 1994, pp 553-586.
76. Konturek PCh, Ernst H, Bobrzyński et al. Mucosal expression and luminal release of epidermal and transforming growth factors in duodenal (DU) ulcer patients before and after eradication of H.pylori. J Physiol Pharmacol 1995; 46 (suppl 2): 48-49.
77. Piasecki C. Role of ischaemia in the initiation of peptic ulcer. Ann R Coll Surg Engl 1977; 59: 476-478.
78. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
79. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1988; 11: 1437-1442.
80. Negrini R, Lisato L, Zanella I et al. Helicobacter pylori infection induces antibodies cross-reactings with human gastric mucosa. Gastroenterology 1991; 101: 437-445.